{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:30:35Z","timestamp":1786419035268,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-026-01351-2","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:05:09Z","timestamp":1786417509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Big Data Analytics in Urologic Oncology: A Comprehensive Review of Large-scale Database Research and Clinical Applications"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-0739","authenticated-orcid":false,"given":"Ali","family":"Bourgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"1351_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","volume":"319","author":"AL Beam","year":"2018","unstructured":"Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319:1317\u20138. https:\/\/doi.org\/10.1001\/jama.2017.18391.","journal-title":"JAMA"},{"key":"1351_CR2","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jama.2013.393","volume":"309","author":"TB Murdoch","year":"2013","unstructured":"Murdoch TB, Detsky AS. The inevitable application of big data to health care. JAMA. 2013;309:1351\u20132. https:\/\/doi.org\/10.1001\/jama.2013.393.","journal-title":"JAMA"},{"key":"1351_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2047-2501-2-3","volume":"2","author":"W Raghupathi","year":"2014","unstructured":"Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014;2:3. https:\/\/doi.org\/10.1186\/2047-2501-2-3.","journal-title":"Health Inf Sci Syst"},{"key":"1351_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41746-019-0099-5","volume":"2","author":"EM Cahan","year":"2019","unstructured":"Cahan EM, Hernandez-Boussard T, Thadaney-Israni S, Rubin DL. Putting the data before the algorithm in big data: addressing personalized healthcare. NPJ Digit Med. 2019;2:14. https:\/\/doi.org\/10.1038\/s41746-019-0099-5.","journal-title":"NPJ Digit Med"},{"key":"1351_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.7326\/M18-1990","volume":"169","author":"A Rajkomar","year":"2018","unstructured":"Rajkomar A, Hardt M, Howell MD, Corrado G, Chin MH. Ensuring fairness in machine learning to advance health equity. Ann Intern Med. 2018;169:866\u201372. https:\/\/doi.org\/10.7326\/M18-1990.","journal-title":"Ann Intern Med"},{"key":"1351_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.eururo.2014.07.032","volume":"66","author":"KR Ghani","year":"2014","unstructured":"Ghani KR, Zheng K, Wei JT, Friedman CP. Harnessing big data for health care and research: are urologists ready? Eur Urol. 2014;66:975\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2014.07.032.","journal-title":"Eur Urol"},{"key":"1351_CR7","doi-asserted-by":"publisher","first-page":"175628722199815","DOI":"10.1177\/1756287221998157","volume":"13","author":"N Naik","year":"2021","unstructured":"Naik N, Hegde P, Rai BP, Somani BK. Big data analytics in urology: the story so far and the road ahead. Ther Adv Urol. 2021;13:1756287221998157. https:\/\/doi.org\/10.1177\/1756287221998157.","journal-title":"Ther Adv Urol"},{"key":"1351_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.urolonc.2021.01.014","volume":"39","author":"ZR Leopold","year":"2021","unstructured":"Leopold ZR, Dave P, Menon A, et al. Trends in the use of administrative databases in urologic oncology: 2000\u20132019. Urol Oncol. 2021;39:487\u201392. https:\/\/doi.org\/10.1016\/j.urolonc.2021.01.014.","journal-title":"Urol Oncol"},{"key":"1351_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.juro.2013.07.096","volume":"191","author":"BJ Schlomer","year":"2014","unstructured":"Schlomer BJ, Copp HL. Secondary data analysis of large data sets in urology: successes and errors to avoid. J Urol. 2014;191:587\u201396. https:\/\/doi.org\/10.1016\/j.juro.2013.07.096.","journal-title":"J Urol"},{"key":"1351_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/MOU.0000000000000406","volume":"27","author":"MD Tyson","year":"2017","unstructured":"Tyson MD, Barocas DA. Improving quality through clinical registries in urology. Curr Opin Urol. 2017;27:375\u20139. https:\/\/doi.org\/10.1097\/MOU.0000000000000406.","journal-title":"Curr Opin Urol"},{"key":"1351_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/bju.14852","volume":"124","author":"J Chen","year":"2019","unstructured":"Chen J, Remulla D, Nguyen JH, et al. Current status of artificial intelligence applications in urology and their potential to influence clinical practice. BJU Int. 2019;124:567\u201377. https:\/\/doi.org\/10.1111\/bju.14852.","journal-title":"BJU Int"},{"key":"1351_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.23736\/S0393-2249.19.03613-0","volume":"72","author":"E Checcucci","year":"2020","unstructured":"Checcucci E, Autorino R, Cacciamani GE, et al. Artificial intelligence and neural networks in urology: current clinical applications. Minerva Urol Nefrol. 2020;72:49\u201357. https:\/\/doi.org\/10.23736\/S0393-2249.19.03613-0.","journal-title":"Minerva Urol Nefrol"},{"key":"1351_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/MOU.0000000000000814","volume":"30","author":"E Checcucci","year":"2020","unstructured":"Checcucci E, De Cillis S, Granato S, et al. Applications of neural networks in urology: a systematic review. Curr Opin Urol. 2020;30:788\u2013807. https:\/\/doi.org\/10.1097\/MOU.0000000000000814.","journal-title":"Curr Opin Urol"},{"issue":"Suppl 1","key":"1351_CR14","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.5152\/tud.2020.20282","volume":"46","author":"M Shah","year":"2020","unstructured":"Shah M, Naik N, Somani BK, et al. Artificial intelligence in urology: current use and future directions: an iTRUE study. Turk J Urol. 2020;46(Suppl 1):S27\u201339. https:\/\/doi.org\/10.5152\/tud.2020.20282.","journal-title":"Turk J Urol"},{"key":"1351_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-019-0193-3","volume":"16","author":"SL Goldenberg","year":"2019","unstructured":"Goldenberg SL, Nir G, Salcudean SE. A new era: artificial intelligence and machine learning in prostate cancer. Nat Rev Urol. 2019;16:391\u2013403. https:\/\/doi.org\/10.1038\/s41585-019-0193-3.","journal-title":"Nat Rev Urol"},{"key":"1351_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/RRU.S000000","volume":"17","author":"R Cicchetti","year":"2025","unstructured":"Cicchetti R, Amparore D, Tamborino F, et al. The use of artificial intelligence in urologic oncology. Res Rep Urol. 2025;17:293\u2013308. https:\/\/doi.org\/10.2147\/RRU.S000000.","journal-title":"Res Rep Urol"},{"key":"1351_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1001\/jamasurg.2018.2429","volume":"153","author":"AJ Hung","year":"2018","unstructured":"Hung AJ, Chen J, Gill IS. Automated performance metrics and machine learning algorithms to measure surgeon performance and anticipate clinical outcomes in robotic surgery. JAMA Surg. 2018;153:770\u20131. https:\/\/doi.org\/10.1001\/jamasurg.2018.2429.","journal-title":"JAMA Surg"},{"key":"1351_CR18","first-page":"46","volume":"19","author":"JJ Azzolina","year":"2017","unstructured":"Azzolina JJ. Data analytics in the large urology practice: patient identification, population management, and protocol adherence. Rev Urol. 2017;19:46\u201352.","journal-title":"Rev Urol"},{"key":"1351_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.13063\/2327-9214.1231","volume":"4","author":"T Hernandez-Boussard","year":"2016","unstructured":"Hernandez-Boussard T, Tamang S, Blayney D, Brooks JD. New paradigms for patient-centered outcomes research in electronic medical records: an example of detecting urinary incontinence following prostatectomy. EGEMS (Wash DC). 2016;4:1231. https:\/\/doi.org\/10.13063\/2327-9214.1231.","journal-title":"EGEMS (Wash DC)"},{"key":"1351_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/RRU.S233777","volume":"12","author":"K Li","year":"2020","unstructured":"Li K, Banerjee I, Magnani CJ, et al. Clinical documentation to predict factors associated with urinary incontinence following prostatectomy for prostate cancer. Res Rep Urol. 2020;12:7\u201314. https:\/\/doi.org\/10.2147\/RRU.S233777.","journal-title":"Res Rep Urol"},{"key":"1351_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.13063\/2327-9214.1220","volume":"4","author":"AJ Knighton","year":"2016","unstructured":"Knighton AJ, Belnap T, Brunisholz K, et al. Using electronic health record data to identify prostate cancer patients that may qualify for active surveillance. EGEMS (Wash DC). 2016;4:1220. https:\/\/doi.org\/10.13063\/2327-9214.1220.","journal-title":"EGEMS (Wash DC)"},{"key":"1351_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/UPJ.0000000000000133","volume":"8","author":"F Gaylis","year":"2021","unstructured":"Gaylis F, Nasseri R, Swift S, et al. Leveraging the electronic medical record improves prostate cancer clinical staging in a community urology practice. Urol Pract. 2021;8:47\u201352. https:\/\/doi.org\/10.1097\/UPJ.0000000000000133.","journal-title":"Urol Pract"},{"key":"1351_CR23","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/cncr.30028","volume":"122","author":"JD Shirk","year":"2016","unstructured":"Shirk JD, Kwon YS, Saigal CS, Litwin MS. Patient experience and quality of urologic cancer surgery in US hospitals. Cancer. 2016;122:2571\u20138. https:\/\/doi.org\/10.1002\/cncr.30028.","journal-title":"Cancer"},{"key":"1351_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1590\/S1677-5538.IBJU.2019.0648","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Han H, Xue Y, et al. Comparison and trend of perioperative outcomes between robot-assisted radical prostatectomy and open radical prostatectomy: Nationwide Inpatient Sample 2009\u20132014. Int Braz J Urol. 2020;46:754\u201371. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2019.0648.","journal-title":"Int Braz J Urol"},{"key":"1351_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/pcan.2016.39","volume":"19","author":"C Groeben","year":"2016","unstructured":"Groeben C, Koch R, Baunacke M, et al. Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013. Prostate Cancer Prostatic Dis. 2016;19:412\u20136. https:\/\/doi.org\/10.1038\/pcan.2016.39.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1351_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00345-024-05291-9","volume":"42","author":"H Crespin","year":"2024","unstructured":"Crespin H, Lecuyer AI, Laurent E, Bruyere F, Grammatico-Guillon L. Incidence and mortality of prostate cancer in France from 2010 to 2021, using a real-life database (National Health Data System - SNDS) - the CaPCo Study. World J Urol. 2024;42:597. https:\/\/doi.org\/10.1007\/s00345-024-05291-9.","journal-title":"World J Urol"},{"key":"1351_CR27","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.canep.2020.101833","volume":"69","author":"NH Thurin","year":"2020","unstructured":"Thurin NH, Rouyer M, Gross-Goupil M, Rebillard X, Souli\u00e9 M, Haaser T, Roumigui\u00e9 M, Le Moulec S, Capone C, Pierr\u00e8s M, et al. Epidemiology of metastatic castration-resistant prostate cancer: a first estimate of incidence and prevalence using the French nationwide healthcare database. Cancer Epidemiol. 2020;69:101833. https:\/\/doi.org\/10.1016\/j.canep.2020.101833.","journal-title":"Cancer Epidemiol"},{"key":"1351_CR28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1080\/17512433.2022.2115356","volume":"15","author":"NH Thurin","year":"2022","unstructured":"Thurin NH, Rouyer M, Jov\u00e9 J, Gross-Goupil M, Haaser T, R\u00e9billard X, Souli\u00e9 M, de Pouvourville G, Capone C, Bazil ML, et al. Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database. Expert Rev Clin Pharmacol. 2022;15:1139\u201345. https:\/\/doi.org\/10.1080\/17512433.2022.2115356.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1351_CR29","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/j.clgc.2023.04.004","volume":"21","author":"LM Scailteux","year":"2023","unstructured":"Scailteux LM, Vincendeau S, Gravis G, Mathieu R, Balusson F, Kerbrat S, Oger E. Real-world treatment patterns among French patients with metastatic castration-resistant prostate cancer under abiraterone or enzalutamide. Clin Genitourin Cancer. 2023;21:e362\u20139. https:\/\/doi.org\/10.1016\/j.clgc.2023.04.004.","journal-title":"Clin Genitourin Cancer"},{"key":"1351_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/gcc.22760","volume":"58","author":"J Grimm","year":"2019","unstructured":"Grimm J, Zeuschner P, Janssen M, et al. Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations. Genes Chromosomes Cancer. 2019;58:612\u20138. https:\/\/doi.org\/10.1002\/gcc.22760.","journal-title":"Genes Chromosomes Cancer"},{"key":"1351_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.eururo.2019.07.033","volume":"76","author":"CW Jeong","year":"2019","unstructured":"Jeong CW, Cowan JE, Broering JM, et al. Robust health utility assessment among long-term survivors of prostate cancer: results from the CaPSURE registry. Eur Urol. 2019;76:743\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.07.033.","journal-title":"Eur Urol"},{"key":"1351_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.urology.2023.07.007","volume":"180","author":"YB Shah","year":"2023","unstructured":"Shah YB, Goldberg H, Hu B, Daneshmand S, Chandrasekar T. Metastatic testicular cancer patterns and predictors: a contemporary population-based SEER analysis. Urology. 2023;180:182\u20139. https:\/\/doi.org\/10.1016\/j.urology.2023.07.007.","journal-title":"Urology"},{"key":"1351_CR33","doi-asserted-by":"publisher","first-page":"e2379","DOI":"10.1016\/j.urolonc.2017.12.015","volume":"36","author":"AB Weiner","year":"2018","unstructured":"Weiner AB, Keeter MK, Manjunath A, Meeks JJ. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: an update from the National Cancer Data Base (2004\u20132013). Urol Oncol. 2018;36:e2379\u201323717. https:\/\/doi.org\/10.1016\/j.urolonc.2017.12.015.","journal-title":"Urol Oncol"},{"key":"1351_CR34","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2012.475","volume":"307","author":"HJ Tan","year":"2012","unstructured":"Tan HJ, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;307:1629\u201335. https:\/\/doi.org\/10.1001\/jama.2012.475.","journal-title":"JAMA"},{"key":"1351_CR35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Krasnow RE, Bellmunt J, et al. Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol. 2017;35:852\u201360. https:\/\/doi.org\/10.1200\/JCO.2016.69.4141.","journal-title":"J Clin Oncol"},{"key":"1351_CR36","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.eururo.2013.11.012","volume":"65","author":"SH Culp","year":"2014","unstructured":"Culp SH, Schellhammer PF, Williams MB. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol. 2014;65:1058\u201366. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.012.","journal-title":"Eur Urol"},{"key":"1351_CR37","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1002\/cam4.70060","volume":"13","author":"S Mao","year":"2024","unstructured":"Mao S, Samiei A, Yin Y, et al. The survival outcomes of localized low-risk prostate cancer: a population-based study using NCDB. Cancer Med. 2024;13:e70060. https:\/\/doi.org\/10.1002\/cam4.70060.","journal-title":"Cancer Med"},{"key":"1351_CR38","doi-asserted-by":"publisher","first-page":"e2400284","DOI":"10.1200\/CCI-24-00284","volume":"9","author":"M Roach","year":"2025","unstructured":"Roach M 3rd, Zhang J, Mohamad O, et al. Assessing algorithmic fairness with a multimodal artificial intelligence model in men of African and non-African origin on NRG Oncology prostate cancer trials. JCO Clin Cancer Inf. 2025;9:e2400284. https:\/\/doi.org\/10.1200\/CCI-24-00284.","journal-title":"JCO Clin Cancer Inf"},{"key":"1351_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41551-023-01056-8","volume":"7","author":"J Lipkova","year":"2023","unstructured":"Lipkova J, Lu MY, Sahai S, et al. Algorithm fairness in artificial intelligence for medicine and healthcare. Nat Biomed Eng. 2023;7:719\u201342. https:\/\/doi.org\/10.1038\/s41551-023-01056-8.","journal-title":"Nat Biomed Eng"},{"key":"1351_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","volume":"70","author":"CJ Wallis","year":"2016","unstructured":"Wallis CJ, Saskin R, Choo R, et al. Surgery versus radiotherapy for clinically localized prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;70:21\u201330. https:\/\/doi.org\/10.1016\/j.eururo.2015.11.010.","journal-title":"Eur Urol"},{"key":"1351_CR41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ejso.2016.11.011","volume":"43","author":"R Autorino","year":"2017","unstructured":"Autorino R, Porpiglia F, Dasgupta P, et al. Precision surgery and genitourinary cancers. Eur J Surg Oncol. 2017;43:893\u2013908. https:\/\/doi.org\/10.1016\/j.ejso.2016.11.011.","journal-title":"Eur J Surg Oncol"},{"key":"1351_CR42","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3390\/cancers14133135","volume":"14","author":"O Eminaga","year":"2022","unstructured":"Eminaga O, Shkolyar E, Breil B, et al. Artificial intelligence-based prognostic model for urologic cancers: a SEER-based study. Cancers (Basel). 2022;14:3135. https:\/\/doi.org\/10.3390\/cancers14133135.","journal-title":"Cancers (Basel)"},{"key":"1351_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamasurg.2018.1680","volume":"153","author":"SB Williams","year":"2018","unstructured":"Williams SB, Shan Y, Jazzar U, et al. Comparing survival outcomes and costs associated with radical cystectomy and trimodal therapy for older adults with muscle-invasive bladder cancer. JAMA Surg. 2018;153:881\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2018.1680.","journal-title":"JAMA Surg"},{"key":"1351_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","volume":"21","author":"P Str\u00f6m","year":"2020","unstructured":"Str\u00f6m P, Kartasalo K, Olsson H, et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020;21:222\u201332. https:\/\/doi.org\/10.1016\/S1470-2045(19)30738-7.","journal-title":"Lancet Oncol"},{"key":"1351_CR45","doi-asserted-by":"publisher","first-page":"e232635","DOI":"10.1148\/radiol.232635","volume":"312","author":"DJ Winkel","year":"2024","unstructured":"Winkel DJ, Brifman E, Menkovski V, et al. Fully automated deep learning model to detect clinically significant prostate cancer at MRI. Radiology. 2024;312:e232635. https:\/\/doi.org\/10.1148\/radiol.232635.","journal-title":"Radiology"},{"key":"1351_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"1351_CR47","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1200\/JCO.2015.65.4155","volume":"34","author":"MD Galsky","year":"2016","unstructured":"Galsky MD, Stensland KD, Moshier E, et al. Effectiveness of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the real world: results from the National Cancer Data Base. J Clin Oncol. 2016;34:1805\u201312. https:\/\/doi.org\/10.1200\/JCO.2015.65.4155.","journal-title":"J Clin Oncol"},{"key":"1351_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.eururo.2011.11.028","volume":"61","author":"M Sun","year":"2012","unstructured":"Sun M, Trinh QD, Bianchi M, et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol. 2012;61:725\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2011.11.028.","journal-title":"Eur Urol"},{"key":"1351_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jnci\/djj190","volume":"98","author":"AJ Stephenson","year":"2006","unstructured":"Stephenson AJ, Kattan MW, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98:715\u20137. https:\/\/doi.org\/10.1093\/jnci\/djj190.","journal-title":"J Natl Cancer Inst"},{"key":"1351_CR50","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1200\/JCO.2005.05.2158","volume":"24","author":"SF Shariat","year":"2006","unstructured":"Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. J Clin Oncol. 2006;24:3967\u201372. https:\/\/doi.org\/10.1200\/JCO.2005.05.2158.","journal-title":"J Clin Oncol"},{"key":"1351_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.ju.0000141581.19533.d8","volume":"173","author":"M Sorbellini","year":"2005","unstructured":"Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative nomogram for prediction of recurrence in conventional clear cell renal cell carcinoma. J Urol. 2005;173:48\u201351. https:\/\/doi.org\/10.1097\/01.ju.0000141581.19533.d8.","journal-title":"J Urol"},{"key":"1351_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","volume":"366","author":"Z Obermeyer","year":"2019","unstructured":"Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366:447\u201353. https:\/\/doi.org\/10.1126\/science.aax2342.","journal-title":"Science"},{"key":"1351_CR53","doi-asserted-by":"publisher","first-page":"e208618","DOI":"10.1001\/jamanetworkopen.2020.8618","volume":"3","author":"A Kamran","year":"2020","unstructured":"Kamran A, Seisen T, Preston MA, et al. Evaluation of cancer registry data for comparative effectiveness research: a replication of 141 randomized trials. JAMA Netw Open. 2020;3:e208618. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.8618.","journal-title":"JAMA Netw Open"},{"key":"1351_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4111\/icu.2020.61.1.1","volume":"61","author":"J Kim","year":"2020","unstructured":"Kim J, Jin P, Kim W, Kim J. Utilizing machine learning to discern hidden clinical values from big data in urology. Investig Clin Urol. 2020;61:1\u201313. https:\/\/doi.org\/10.4111\/icu.2020.61.1.1.","journal-title":"Investig Clin Urol"},{"key":"1351_CR55","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","volume":"31","author":"AA Aizer","year":"2013","unstructured":"Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31:3869\u201376. https:\/\/doi.org\/10.1200\/JCO.2013.49.6489.","journal-title":"J Clin Oncol"},{"key":"1351_CR56","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.eururo.2019.04.016","volume":"76","author":"S Berg","year":"2019","unstructured":"Berg S, Cole AP, Krimphove MJ, et al. Comparative effectiveness of radical prostatectomy versus external beam radiation therapy plus brachytherapy in patients with high-risk localized prostate cancer. Eur Urol. 2019;76:332\u201340. https:\/\/doi.org\/10.1016\/j.eururo.2019.04.016.","journal-title":"Eur Urol"},{"key":"1351_CR57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0300-7.","journal-title":"Nat Med"},{"key":"1351_CR58","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MOU.0000000000000956","volume":"32","author":"IM van Oort","year":"2022","unstructured":"van Oort IM, van Montfoort DO, Lysenko I, Meijer RP. Ethical aspects of artificial intelligence: what urologists need to know. Curr Opin Urol. 2022;32:342\u20137. https:\/\/doi.org\/10.1097\/MOU.0000000000000956.","journal-title":"Curr Opin Urol"},{"key":"1351_CR59","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1001\/jama.2019.18058","volume":"322","author":"RB Parikh","year":"2019","unstructured":"Parikh RB, Teeple S, Navathe AS. Addressing bias in artificial intelligence in health care. JAMA. 2019;322:2377\u20138. https:\/\/doi.org\/10.1001\/jama.2019.18058.","journal-title":"JAMA"},{"key":"1351_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.eururo.2019.08.017","volume":"77","author":"A Sujenthiran","year":"2020","unstructured":"Sujenthiran A, Charman SC, Parry MG, et al. Hospital-level variation in radical prostatectomy outcomes in the United Kingdom: implications for cancer service reconfiguration. Eur Urol. 2020;77:20\u20131. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.017.","journal-title":"Eur Urol"},{"key":"1351_CR61","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/JU.0000000000001157","volume":"204","author":"S Loeb","year":"2020","unstructured":"Loeb S, Bayne CE, Frey C, et al. Use of artificial intelligence in urology: a 2020 vision. J Urol. 2020;204:868\u201375. https:\/\/doi.org\/10.1097\/JU.0000000000001157.","journal-title":"J Urol"},{"key":"1351_CR62","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1200\/JCO.2009.27.5257","volume":"28","author":"KA Moses","year":"2010","unstructured":"Moses KA, Penson DF, Mallin K, et al. Impact of sociodemographic factors and provider volume on racial differences in treatment of localized prostate cancer. J Clin Oncol. 2010;28:4499\u2013505. https:\/\/doi.org\/10.1200\/JCO.2009.27.5257.","journal-title":"J Clin Oncol"},{"key":"1351_CR63","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563\u201377. https:\/\/doi.org\/10.1148\/radiol.2015151169.","journal-title":"Radiology"},{"key":"1351_CR64","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1200\/JCO.2012.47.2002","volume":"31","author":"C Fung","year":"2013","unstructured":"Fung C, Fossa SD, Milano MT, Travis LB. Solid tumors after chemotherapy or surgery for testicular cancer: a population-based study. J Clin Oncol. 2013;31:3807\u201314. https:\/\/doi.org\/10.1200\/JCO.2012.47.2002.","journal-title":"J Clin Oncol"},{"key":"1351_CR65","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1209978","volume":"368","author":"MJ Resnick","year":"2013","unstructured":"Resnick MJ, Koyama T, Fan KH, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368:436\u201345. https:\/\/doi.org\/10.1056\/NEJMoa1209978.","journal-title":"N Engl J Med"},{"key":"1351_CR66","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375:1425\u201337. https:\/\/doi.org\/10.1056\/NEJMoa1606221.","journal-title":"N Engl J Med"},{"key":"1351_CR67","doi-asserted-by":"publisher","first-page":"12334","DOI":"10.1038\/s41598-020-68987-8","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen L, Lu W, Zhang YH, et al. An artificial intelligence-based diagnostic and prognostic prediction model for prostate cancer. Sci Rep. 2020;10:12334. https:\/\/doi.org\/10.1038\/s41598-020-68987-8.","journal-title":"Sci Rep"},{"key":"1351_CR68","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.urolonc.2022.03.003","volume":"40","author":"M Wenzel","year":"2022","unstructured":"Wenzel M, Nocera L, Coll\u00e0 Ruvolo C, et al. Evolution of machine learning algorithms for outcome prediction in prostate cancer. Urol Oncol. 2022;40:271\u201382. https:\/\/doi.org\/10.1016\/j.urolonc.2022.03.003.","journal-title":"Urol Oncol"},{"key":"1351_CR69","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1200\/JCO.2015.63.6450","volume":"34","author":"B Loppenberg","year":"2016","unstructured":"Loppenberg B, Dalela D, Karabon P, et al. The impact of marital status on survival of patients with bladder cancer. J Clin Oncol. 2016;34:868\u201370. https:\/\/doi.org\/10.1200\/JCO.2015.63.6450.","journal-title":"J Clin Oncol"},{"key":"1351_CR70","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/cncr.30415","volume":"123","author":"MJ Maurice","year":"2017","unstructured":"Maurice MJ, Zhu H, Kim SP, et al. Reconsidering the role of lymph node dissection in partial nephrectomy for renal cell carcinoma: an analysis of the National Cancer Data Base. Cancer. 2017;123:1157\u201365. https:\/\/doi.org\/10.1002\/cncr.30415.","journal-title":"Cancer"},{"key":"1351_CR71","doi-asserted-by":"publisher","unstructured":"Audenet F, Yates DR, Cockerill PA, et al. National trends in inpatient complications after surgery for renal tumors from 1998 to 2010. Urol Oncol. 2015;33:167.e15\u2013167.e24. https:\/\/doi.org\/10.1016\/j.urolonc.2015.01.003","DOI":"10.1016\/j.urolonc.2015.01.003"},{"key":"1351_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41591-019-0640-6","volume":"26","author":"IY Chen","year":"2020","unstructured":"Chen IY, Joshi S, Ghassemi M. Treating health disparities with artificial intelligence. Nat Med. 2020;26:16\u20137. https:\/\/doi.org\/10.1038\/s41591-019-0640-6.","journal-title":"Nat Med"},{"key":"1351_CR73","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.juro.2016.03.170","volume":"196","author":"C Ellimoottil","year":"2016","unstructured":"Ellimoottil C, Vijan S, Flanigan RC, Miller DC. Health system variation in the outcomes of surgery for kidney cancer: implications for rational centralized care. J Urol. 2016;196:698\u2013704. https:\/\/doi.org\/10.1016\/j.juro.2016.03.170.","journal-title":"J Urol"},{"key":"1351_CR74","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388:2796\u2013810. https:\/\/doi.org\/10.1016\/S0140-6736(16)30512-8.","journal-title":"Lancet"},{"key":"1351_CR75","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.eururo.2018.06.021","volume":"74","author":"N Hanna","year":"2018","unstructured":"Hanna N, Trinh QD, Seisen T, et al. Effectiveness of local therapy for metastatic prostate cancer: a systematic review and meta-analysis. Eur Urol. 2018;74:421\u201335. https:\/\/doi.org\/10.1016\/j.eururo.2018.06.021.","journal-title":"Eur Urol"},{"key":"1351_CR76","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella G, Hanna MG, Geneslaw L, et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat Med. 2019;25:1301\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0508-1.","journal-title":"Nat Med"},{"key":"1351_CR77","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1200\/JCO.2017.74.2940","volume":"36","author":"DE Spratt","year":"2018","unstructured":"Spratt DE, Zhang J, Santiago-Jim\u00e9nez M, et al. Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer. J Clin Oncol. 2018;36:581\u201390. https:\/\/doi.org\/10.1200\/JCO.2017.74.2940.","journal-title":"J Clin Oncol"},{"key":"1351_CR78","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2019.05.047","volume":"76","author":"SS Butler","year":"2019","unstructured":"Butler SS, Muralidhar V, Zhao SG, et al. Active surveillance for low-risk prostate cancer in the real world: outcomes across diverse centers. Eur Urol. 2019;76:402\u20134. https:\/\/doi.org\/10.1016\/j.eururo.2019.05.047.","journal-title":"Eur Urol"},{"key":"1351_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaoncol.2021.5314","volume":"8","author":"JM Lobo","year":"2022","unstructured":"Lobo JM, Stensland KD, Galsky MD. Clinical trials versus real-world data to inform regulatory decisions. JAMA Oncol. 2022;8:15\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5314.","journal-title":"JAMA Oncol"},{"key":"1351_CR80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.radonc.2018.11.015","volume":"132","author":"AO Naghavi","year":"2019","unstructured":"Naghavi AO, Echevarria MI, Grass GD, et al. Clinical outcomes following trimodality therapy versus radical cystectomy for muscle-invasive bladder cancer: a multi-institutional comparative analysis. Radiother Oncol. 2019;132:175\u201381. https:\/\/doi.org\/10.1016\/j.radonc.2018.11.015.","journal-title":"Radiother Oncol"},{"key":"1351_CR81","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1200\/JCO.2014.60.2557","volume":"33","author":"MJ Resnick","year":"2015","unstructured":"Resnick MJ, Lacchetti C, Bergman J, et al. Prostate cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2015;33:1078\u201385. https:\/\/doi.org\/10.1200\/JCO.2014.60.2557.","journal-title":"J Clin Oncol"},{"key":"1351_CR82","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bju.15419","volume":"128","author":"D D\u2019Andrea","year":"2021","unstructured":"D\u2019Andrea D, Gontero P, Shariat SF. Is artificial intelligence ready to improve the management of bladder cancer? BJU Int. 2021;128:388\u20139. https:\/\/doi.org\/10.1111\/bju.15419.","journal-title":"BJU Int"},{"key":"1351_CR83","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1200\/JCO.19.02010","volume":"38","author":"JH Lewis","year":"2020","unstructured":"Lewis JH, Kilari D, Bosserman LD, et al. Embedded clinical trials: a new model for drug development in bladder cancer. J Clin Oncol. 2020;38:1831\u201343. https:\/\/doi.org\/10.1200\/JCO.19.02010.","journal-title":"J Clin Oncol"},{"key":"1351_CR84","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.urolonc.2018.06.017","volume":"36","author":"BT Ristau","year":"2018","unstructured":"Ristau BT, Kamat AM, Tarin TV, et al. Optimal outcomes and best practices for surgical care in testicular cancer: a review from the Society of Urologic Oncology. Urol Oncol. 2018;36:445\u201355. https:\/\/doi.org\/10.1016\/j.urolonc.2018.06.017.","journal-title":"Urol Oncol"},{"key":"1351_CR85","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/JU.0000000000000453","volume":"202","author":"A Larcher","year":"2019","unstructured":"Larcher A, Gandaglia G, Panotopoulos J, et al. Multicenter validation of the prognostic value of tumor burden in patients with metastatic hormone-sensitive prostate cancer. J Urol. 2019;202:1209\u201318. https:\/\/doi.org\/10.1097\/JU.0000000000000453.","journal-title":"J Urol"},{"key":"1351_CR86","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.eururo.2013.03.059","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Rink M, Cha EK, et al. Impact of distal ureter management on oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014;65:961\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.059.","journal-title":"Eur Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01351-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:05:14Z","timestamp":1786417514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01351-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01351-2","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"36"}}